Konstantinos Koutsoukos

Author

National and Kapodistrian University of Athens ORCID

Also Known As

K. Koutsoukos, Konstantinos Koutsoukos, Koutsoukos K, Koutsoukos, Konstantinos, Koutsoukos,Konstantinos

Publications

912

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Alexandra Hospital Laiko General Hospital of Athens Dana-Farber Cancer Institute

About

Konstantinos Koutsoukos is an author at National and Kapodistrian University of Athens specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	166
2	Pathology	4	4	76
3	Immunology	3	3	50
4	Cell Biology	1	1	68
5	Obstetrics	1	1	12

Konstantinos Koutsoukos

Publications

418

Citations

H-Index

Page 1

	Year	Citations
Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer Flora Zagouri, Evangelos Bournakis, Konstantinos Koutsoukos, Pharmaceuticals Tumor BiologyBreast OncologyProtein ExpressionMedicineCancer Cell Biology	2012	68
Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consortium Frede Donskov, Wanling Xie, A. J. Overby, European Urology Oncology	2020	56
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy M. Liontos, A. Andrikopoulou, Konstantinos Koutsoukos, Journal of Ovarian Research	2021	33
Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis Αngeliki Andrikopoulou, Eleni Zografos, Kleoniki Apostolidou, Frontiers in Oncology	2022	31
Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma Maria Dimou, Maria K. Angelopoulou, Gerassimos A. Pangalis, Leukemia & lymphoma/Leukemia and lymphoma Hl-associated Aiha/aitpImmunologyPathologyImmunotherapyHematological Malignancy	2012	28
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma Stefanie Fischer, Torgrim Tandstad, Gabriella Cohn‐Cedermark, Journal of Clinical Oncology	2019	28
The Development of an Angiogenic Protein “Signature” in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling Sofia-Paraskevi Trachana, Eleftherios Pilalis, Nikos G. Gavalas, PLoS ONE	2016	27
Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients Michalis Liontos, Eleni‐Andriana Trigka, Penelope Korkolopoulou, World Journal of Urology Pathway ProteinsUrologyOncologyGenitourinary CancerMedicine	2016	24
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors Flora Zagouri, Evangelos Terpos, Oraianthi Fiste, The Breast	2021	21
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival Stavroula Α. Paschou, Evangelos Eleftherakis-Papaiakovou, Katerina Stefanaki, Frontiers in Oncology	2022	20

Page 1